Please assess the completion status of the following clinical trial:

Trial Title: Effect of High and Low Sodium Diets on Blood Pressure in Hypertensive Patients Treated With Aliskiren

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female outpatients 18-60 years old~* Patients with systolic hypertension who met the 24 hour Ambulatory Blood Pressure Monitoring (ABPM) criteria (ABPM mean daytime Systolic Blood Pressure (SBP) \>= 135 mmHg and \< 160 mmHg)~Exclusion Criteria:~* Overt heart failure (HF) or a history of heart failure within preceding 6 months.~* Unstable angina pectoris.~* Type 1 or Type 2 diabetes mellitus or abnormal hemoglobin A1c(HbA1c)~* Body mass index (BMI) \> 30 kg/m2~* Subjects taking more than 2 antihypertensive medications.~* Use of other investigational drugs within 30 days of the time of enrollment~* Use of Tamsulosin hydrochloride and other alpha blockers.~* Use of Antiarrhythmic drugs, including digoxin.~* History of MI or cardiovascular attack (CVA) within the preceding 6 months.~* History of malignancy of any organ system, treated or untreated, within the past 5 years with the exception of localized basal cell carcinoma of the skin~* Pregnant or nursing (lactating) women

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Diet Sequence Low/High Sodium (Type: EXPERIMENTAL): Patients on low sodium diet ( \<= 100 mmol/day) for the first 4 weeks and high sodium (\>= 200 mmol/day) diet for the next 4 weeks. \[with Aliskiren 300 mg\]
- Diet Sequence High/Low Sodium (Type: EXPERIMENTAL): Patients on high sodium (\>= 200 mmol/day) diet for the first 4 weeks and on low sodium diet ( \<= 100 mmol/day) for the next 4 weeks. \[with Aliskiren 300 mg\]

Based on this trial design, predict the completion outcome and termination type (if applicable).